Johnson & Johnson Aktie
WKN: 853260 / ISIN: US4781601046
17.10.2014 15:27:10
|
Court Grants Covidien Preliminary Injunction Against Ethicon's Harmonic ACE+7
(RTTNews) - Covidien plc (COV) announced Friday that the U.S. District Court for the District of Connecticut has granted a preliminary injunction against Ethicon Endo-Surgery, Inc., a Johnson & Johnson (JNJ) company.
The injunction results from a lawsuit filed by Covidien in June 2014 that alleged Ethicon's latest ultrasonic surgical product, the Harmonic ACE+7, infringes three Covidien patents.
The injunction prevents Ethicon from manufacturing, marketing and selling the Harmonic ACE+7.
The June 2014 lawsuit contends that U.S. Patents 6,063,050; 6,468,286; and 6,682,544 are infringed by Ethicon's Harmonic ACE+7 Shears. Ethicon's Harmonic devices were found to infringe the same patents in a prior suit in the same court that resulted in a damages award against Ethicon of more than $175 million, a finding that is currently under appeal.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
16.05.25 |
Schwache Performance in New York: Dow Jones fällt mittags (finanzen.at) | |
14.05.25 |
Dow Jones-Handel aktuell: Dow Jones zum Ende des Mittwochshandels in der Verlustzone (finanzen.at) | |
14.05.25 |
Dow Jones aktuell: Dow Jones gibt am Mittwochnachmittag nach (finanzen.at) | |
14.05.25 |
Stabiler Handel: So performt der Dow Jones am Mittwochmittag (finanzen.at) | |
14.05.25 |
Dow Jones 30 Industrial-Wert Johnson Johnson-Aktie: So viel hätten Anleger an einem Johnson Johnson-Investment von vor 3 Jahren verloren (finanzen.at) | |
13.05.25 |
NYSE-Handel Dow Jones notiert schlussendlich im Minus (finanzen.at) | |
13.05.25 |
Börse New York in Rot: Dow Jones fällt zurück (finanzen.at) | |
13.05.25 |
Dow Jones-Handel aktuell: Das macht der Dow Jones aktuell (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 135,44 | 0,13% |
|